Nimotuzumab in Combination With Radio-chemotherapy for the Treatment of Brainstem Tumor in Children
Status:
Unknown status
Trial end date:
2019-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of nimotuzumab in
combination of radio-chemotherapy for the treatment of brainstem tumor in children.
Phase:
Phase 2
Details
Lead Sponsor:
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine